Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Treating Concurrent Substance Use Among Adults

About this resource:

Non-Systematic Review

Source: Substance Abuse and Mental Health Services Administration

Last Reviewed: September 2021

Workgroups: Substance Use Workgroup

This Substance Abuse and Mental Health Services Administration (SAMHSA) guide presents 3 evidence-based practices that engage and improve outcomes for people with concurrent substance use and concurrent substance use disorders:

  • FDA-approved pharmacotherapy, together with counseling, to treat alcohol and cocaine dependence or cocaine and opioid dependence
  • Contingency management, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid use and dependence or cocaine dependence and alcohol and opioid use
  • 12-step facilitation therapy, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid dependence or opioid and other substance dependence
Read more about this resource

Objectives related to this resource (1)

Increase the proportion of people with a substance use disorder who got treatment in the past year — SU‑01
Little or no detectable change

Suggested Citation

1.

Substance Abuse and Mental Health Services Administration. (2021). Treating Concurrent Substance Use Among Adults. Retrieved from https://www.samhsa.gov/resource/ebp/treating-concurrent-substance-use-among-adults.